非小细胞肺癌癌症节拍化疗的研究进展

Yue Yu
{"title":"非小细胞肺癌癌症节拍化疗的研究进展","authors":"Yue Yu","doi":"10.3760/CMA.J.ISSN.1008-6315.2020.02.020","DOIUrl":null,"url":null,"abstract":"Advanced non-small cell lung cancer is one of the most difficult malignant tumors in the world. At present, chemotherapy is the most common treatment for NSCLC. However, traditional chemotherapy can kill tumor cells as well as normal cells. In order to solve this problem, metronomic chemotherapy came into being. It can inhibit tumor angiogenesis and tumor growth through a continuous high-frequency, low-dose administration. Metronomic chemotherapy can effectively control the disease progression of advanced NSCLC patients, delay their life span and improve their quality of life. Therefore, metronomic chemotherapy has become an effective treatment for advanced non-small cell lung cancer. \n \n \nKey words: \nLung cancer; Metronomic Chemotherapy; Tumor","PeriodicalId":10365,"journal":{"name":"中国综合临床","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Research Advances of metronomic Chemotherapy in Non-small Cell Lung Cancer\",\"authors\":\"Yue Yu\",\"doi\":\"10.3760/CMA.J.ISSN.1008-6315.2020.02.020\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Advanced non-small cell lung cancer is one of the most difficult malignant tumors in the world. At present, chemotherapy is the most common treatment for NSCLC. However, traditional chemotherapy can kill tumor cells as well as normal cells. In order to solve this problem, metronomic chemotherapy came into being. It can inhibit tumor angiogenesis and tumor growth through a continuous high-frequency, low-dose administration. Metronomic chemotherapy can effectively control the disease progression of advanced NSCLC patients, delay their life span and improve their quality of life. Therefore, metronomic chemotherapy has become an effective treatment for advanced non-small cell lung cancer. \\n \\n \\nKey words: \\nLung cancer; Metronomic Chemotherapy; Tumor\",\"PeriodicalId\":10365,\"journal\":{\"name\":\"中国综合临床\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中国综合临床\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3760/CMA.J.ISSN.1008-6315.2020.02.020\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国综合临床","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1008-6315.2020.02.020","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

晚期癌症是世界上最难治疗的恶性肿瘤之一。目前,化疗是NSCLC最常见的治疗方法。然而,传统的化疗可以杀死肿瘤细胞和正常细胞。为了解决这个问题,节拍化疗应运而生。它可以通过连续的高频、低剂量给药来抑制肿瘤血管生成和肿瘤生长。节拍化疗可以有效控制晚期NSCLC患者的疾病进展,延缓其寿命,提高其生活质量。因此,节拍化疗已成为晚期癌症的有效治疗手段。关键词:肺癌癌症;节拍化疗;肿瘤
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Research Advances of metronomic Chemotherapy in Non-small Cell Lung Cancer
Advanced non-small cell lung cancer is one of the most difficult malignant tumors in the world. At present, chemotherapy is the most common treatment for NSCLC. However, traditional chemotherapy can kill tumor cells as well as normal cells. In order to solve this problem, metronomic chemotherapy came into being. It can inhibit tumor angiogenesis and tumor growth through a continuous high-frequency, low-dose administration. Metronomic chemotherapy can effectively control the disease progression of advanced NSCLC patients, delay their life span and improve their quality of life. Therefore, metronomic chemotherapy has become an effective treatment for advanced non-small cell lung cancer. Key words: Lung cancer; Metronomic Chemotherapy; Tumor
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
0.10
自引率
0.00%
发文量
16855
期刊介绍: Clinical Medicine of China is an academic journal organized by the Chinese Medical Association (CMA), which mainly publishes original research papers, reviews and commentaries in the field. Clinical Medicine of China is a source journal of Peking University (2000 and 2004 editions), a core journal of Chinese science and technology, an academic journal of RCCSE China Core (Extended Edition), and has been published in Chemical Abstracts of the United States (CA), Abstracts Journal of Russia (AJ), Chinese Core Journals (Selection) Database, Chinese Science and Technology Materials Directory, Wanfang Database, China Academic Journal Database, JST Japan Science and Technology Agency Database (Japanese) (2018) and other databases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信